Citation 139809

KONISHI,T: TAKASAKI,M: TOKUDA,H: KIYOSAWA,S: KONOSHIMA,T:. (1998). ANTI-TUMOR-PROMOTING ACTIVITY OF DITERPENES FROM EXCOECARIA AGALLOCHA.. 21(9)

Citation Details

Title	ANTI-TUMOR-PROMOTING ACTIVITY OF DITERPENES FROM EXCOECARIA AGALLOCHA.
Authors	KONISHI,T: TAKASAKI,M: TOKUDA,H: KIYOSAWA,S: KONOSHIMA,T:
Year	1998
Volume	21
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Excoecaria agallocha (EUPHORBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	RIBENONE	None
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBENONE	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OF	MANOYL OXIDE,13-EPI: 11-ALPHA-HYDROXY:	None
4	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE,13-EPI: 11-ALPHA-HYDROXY:	WEAK ACTIVITY
5	Not specified	ISOLATION AND IDENTIFICATION OF	MANOYL OXIDE,13-EPI: 3-ALPHA-HYDROXY:	None
6	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE,13-EPI: 3-ALPHA-HYDROXY:	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OF	MANOYL OXIDE,13-EPI:	None
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE,13-EPI:	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OF	MANOYL OXIDE,13-EPI: 16-HYDROXY-3-OXO: ENT:	None
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE,13-EPI: 16-HYDROXY-3-OXO: ENT:	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OF	LABDA-1-14-DIEN-3-ONE,13-EPI-8-13-EPOXY-2-HYDROXY: ENT:	None
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABDA-1-14-DIEN-3-ONE,13-EPI-8-13-EPOXY-2-HYDROXY: ENT:	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OF	LABD-3-ONE,13-EPI: 8-ALPHA-13-14-15-DIEPOXY: ENT: (13R,14R):	None
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABD-3-ONE,13-EPI: 8-ALPHA-13-14-15-DIEPOXY: ENT: (13R,14R):	ACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OF	LABDA-3-BETA-OL,13-EPI: 8-ALPHA-13-14-15-DIEPOXY: ENT: (13R,14R):	None
16	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABDA-3-BETA-OL,13-EPI: 8-ALPHA-13-14-15-DIEPOXY: ENT: (13R,14R):	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OF	LABD-3-ONE,8-ALPHA-13-14-15-DIEPOXY: ENT:	None
18	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABD-3-ONE,8-ALPHA-13-14-15-DIEPOXY: ENT:	ACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OF	BEYER-15-EN-2-ONE,3-BETA-HYDROXY: ENT:	None
20	ANTITUMOR-PROMOTING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	BEYER-15-EN-2-ONE,3-BETA-HYDROXY: ENT:	ACTIVE
21	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BEYER-15-EN-2-ONE,3-BETA-HYDROXY: ENT:	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OF	BEYER-15-EN-3-ONE	None
23	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BEYER-15-EN-3-ONE	WEAK ACTIVITY
24	Not specified	ISOLATION AND IDENTIFICATION OF	BEYER-15-EN-3-ALPHA-OL: ENT:	None
25	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BEYER-15-EN-3-ALPHA-OL: ENT:	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OF	BEYER-3-ONE,15-16-EPOXY: ENT:	None
27	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BEYER-3-ONE,15-16-EPOXY: ENT:	ACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OF	LABDA-8(17)-TRANS-13-DIEN-3-ONE,15-HYDROXY: ENT:	None
29	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABDA-8(17)-TRANS-13-DIEN-3-ONE,15-HYDROXY: ENT:	ACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OF	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT:	None
31	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT:	ACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OF	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT: DIMETHYL ESTER	None
33	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT: DIMETHYL ESTER	WEAK ACTIVITY
34	Not specified	ISOLATION AND IDENTIFICATION OF	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT: 3-METHYL ESTER	None
35	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LABD-14-ENE-2-3-DIOIC ACID,13-EPI-8-13-EPOXY-2-3-SECO: ENT: 3-METHYL ESTER	ACTIVE

Citation 139809

Citation Details

Summary

Organisms and Their Experiments (1)

Excoecaria agallocha (EUPHORBIACEAE)

Show SPARQL Queries (1)

Query 1